H-KENALLRYLLDKDD-OH

Ref. 3D-PP48369

Produktinformation

• Name: H-KENALLRYLLDKDD-OH

Beschreibung

Peptide H-KENALLRYLLDKDD-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KENALLRYLLDKDD-OH include the following: Structures and mechanism for the design of highly potent glucocorticoids Y He , W Yi , K Suino-Powell, XE Zhou, WD Tolbert - Cell research, 2014 - nature.comhttps://www.nature.com/articles/cr201452 Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains W Huang , Y Peng, J Kiselar , X Zhao - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-06034-2 Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor RR Kroe, MA Baker, MP Brown, NA Farrow - Biophysical , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0301462207000816 Structural mechanisms in the regulation of the thyroid hormone receptor RL Wagner III - 1998 - search.proquest.comhttps://search.proquest.com/openview/94c3c2283cbf88102204e317c89b5089/1?pq-origsite=gscholar&cbl=18750&diss=y Inhibitors for Androgen Receptor Activation Surfaces RJ Fletterick , CALIFORNIA UNIV SAN FRANCISCO - 2007 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA462434 Relating Androgen Receptor Conformation to Function in Prostate Cancer Cells P Webb, CALIFORNIA UNIV SAN FRANCISCO - 2005 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA434610 An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases MJ McPherson, AD Hobson , A Hernandez Jr - Science Translational , 2024 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.add8936 Rational discovery of novel type-III FTF antagonists to competitively suppress TIF-2 coactivation in liver cancer L Xu, Z Chen, K Shao, Y Wang, L Cui - Journal of Receptors , 2019 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/10799893.2019.1690513 Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor L Jiang, D Xiao, Y Li, S Dai, L Qu, X Chen - Biochemical and , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X20319562 Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites L Frego, W Davidson - Protein science, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1110/ps.051781406 Building transcriptional regulatory complexes: signals and surfaces KR Yamamoto, BD Darimont - Cold Spring Harbor , 1998 - symposium.cshlp.orghttps://symposium.cshlp.org/content/63/587.short Mechanisms that regulate androgen receptor transcriptional activity EB Askew - 2010 - cdr.lib.unc.eduhttps://cdr.lib.unc.edu/concern/dissertations/z316q268s Backbone 1H, 13C, and 15N resonance assignments of the ligand binding domain of the human wildtype glucocorticoid receptor and the F602S mutant variant C Köhler, G Carlström, S Taca¥ngefjord - Biomolecular NMR , 2018 - Springerhttps://link.springer.com/article/10.1007/s12104-018-9820-9 Dynamic allosteric communication pathway directing differential activation of the glucocorticoid receptor C Köhler, G Carlström, A Gunnarsson , U Weininger - Science , 2020 - science.orghttps://www.science.org/doi/abs/10.1126/sciadv.abb5277 Structure and specificity of nuclear receptor-coactivator interactions BD Darimont, RL Wagner, JW Apriletti - Genes & , 1998 - genesdev.cshlp.orghttps://genesdev.cshlp.org/content/12/21/3343.short Minimising the payload solvent exposed hydrophobic surface area optimises the antibody-drug conjugate properties AD Hobson , H Zhu, W Qiu, RA Judge - RSC Medicinal , 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/md/d3md00540b

• Marke: Biosynth